>For more information, please visit: https://investor. adagene. com and follow the official accounts of Tianyan Pharmaceutical
What new developments have the participating companies such as Amgen brought to the 40th JPM Healthcare Conference?
Time of Update: 2022-02-23
Retrieved January 11, 2022, from https:// -day-2 Amgen and Arrakis Therapeutics Announce Multi-Target Collaboration to Identify Novel RNA Degrader Small Molecule Therapeutics.
Digital healthcare is welcoming the trend, and it has become a battleground for domestic and foreign pharmaceutical companies
Time of Update: 2021-12-31
At the same time, in China, a large number of multinational pharmaceutical companies are also accelerating their deployment in the domestic digital medical field through cooperation with domestic Internet platforms and medical companies .
How will Internet healthcare develop in 2022?
Time of Update: 2021-12-27
In general, although the development prospects of Internet medical care are broad, enterprises need to standardize their operations if they want to share the market.
NEJM: Study on the effect of BNT162b2 and mRNA-1273 vaccines in the first-line healthcare population
Time of Update: 2021-12-25
Recently, researchers announced the effectiveness of the new coronary pneumonia vaccine in the first-line medical care population .
Zhong Nanshan's team: the origin, intermediate host and sensitization characteristics and hypotheses of SARS-CoV-2｜MDPI Healthcare
Time of Update: 2021-12-02
by researchers in more than 30 developed countries in the United States, Britain, Germany, Japan, Canada, and Russia. Continuous application; put forward the concepts of major representative allergens, antigenic weakening, multi-targeting
Demand dividend continues to be released. Digital healthcare is ushering in the best era!
Time of Update: 2021-11-15
Digital medical content continues to develop along with technological advances, making medical equipment, medical network systems, and medical system-related services more intelligent, providing more efficient integrated services, and helping to improve the service capabilities of medical institutions .
October 2021 Global Healthcare Investment and Financing Monthly Report: The total amount of digital
Time of Update: 2021-11-14
788 billion US dollars, an increase of about 32% from the previous month There were 106 financing projects in the domestic medical and health sector, with a total financing of approximately US$2.
The British Medicines and Healthcare Products Regulatory Agency (MHRA) supports Merck's MET
Time of Update: 2021-10-20
>Recently, the British Medicines and Health Products Regulatory Agency (MHRA) has conditionally authorized Merck's MET inhibitor Teppetko (tepotinib) for the treatment of certain non
NEJM: Breakthrough infection among healthcare workers vaccinated against Covid-19
Time of Update: 2021-10-19
>infections , including infections by health care workers, have been reported . Data is needed to summarize these infections and define
NEJM: BNT162b2 and mRNA-1273 vaccines can effectively prevent the occurrence of symptomatic new coronary pneumonia infections in healthcare population
Time of Update: 2021-10-09
In a real hospital environment, the BNT162b2 and mRNA-1273 vaccines are effective in preventing symptomatic Covid-19 among medical staff.
Oncologist: Clinical outcome, treatment toxicity and healthcare utilization of elderly aggressive non-Hodgkin's lymphoma (NHL)
Time of Update: 2021-08-26
Therefore, a research team from the United States conducted a retrospective study to evaluate the clinical characteristics, prognosis, treatment toxicity, unplanned hospitalization rate, and ICU hospitalization in patients with aggressive non-Hodgkin lymphoma (NHL) aged 65 years or older.
Taking stock of the report on the financing trends of the healthcare industry in the first half
Time of Update: 2021-08-10
Source: Flint Creation Database [Distribution of financing amount] A total of 578 projects received investment from January to June, with a cumulative amount exceeding 115.
Smart healthcare is ushering in a period of development opportunity Sun Yuhang, President of Tide Pharmaceuticals: Helping more patients with digital means
Time of Update: 2021-07-30
With the acceleration of population aging and the increasing demand for health management, the integration and application of cutting-edge technologies such as 5G, big data, "Internet
Genetron Health and Siemens Healthcare reached a strategic cooperation to jointly promote precision diagnosis and treatment of lung cancer
Time of Update: 2021-07-06
More patients with non-small cell lung cancer (NSCLC) will bring efficient and accurate individualized diagnosis and treatment services, and promote the standardization of molecular testing in hospitals .
Another listed pharmaceutical company transforms into healthcare!
Time of Update: 2021-06-11
Changed to "Jimin Medical", the company's full name and securities code remain unchanged, and the date of change of the securities abbreviation is June 4, 2021.